Cytori's Fat Transfer system:
This article was originally published in Clinica
Cytori Therapeutics has gained 510(k) regulatory clearance from the US FDA's Center for Devices and Radiological Health (CDRH) for the Cytori Autologous Fat Transfer (AFT) system. This system is designed to be used to harvest, filter, and transfer a patient's own adipose tissue from one part of their body to another in a single surgical procedure. The San Diego, California company said that the AFT system may be used in the aspiration of soft tissue in many different types of surgery.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.